BTN1A1 and cancer: For example, the use of human TCR transgenic mice combined with the transgenic expression of human BTN molecules is expected to further reveal the biological characteristics of γδT cells and lay the foundation for its application in immunological research.To summarize the current landscape of γδT cell-based cancer therapies and ongoing clinical trials, key findings and approaches are outlined in Table 2 below.